drugset / Trial / NCT00483184

Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease

NCT00483184

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of natural human interferon alpha (IFN alpha) on size, number, incidence and pain of oral ulcers associated with Behçet's Disease (BD).

Timeline

Start
2006-04
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject interferon alfa-2b Protein / enzyme biologic 500 iu Oral
Subject interferon alfa-2b Protein / enzyme biologic 1000 iu Oral